GDRX
Goodrx·NASDAQ
--
--(--)
--
--(--)
GDRX fundamentals
During Q4 2025, Goodrx (GDRX) reported revenue of 194.78M, a YoY change of -1.91%. Net income was 5.42M, a YoY change of -19.51%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 101.75M -- | 113.26M -- | 133.41M -- | 123.30M -- | 140.45M +38.04% | 153.54M +35.57% | 160.43M +20.26% | 176.63M +43.26% | 195.10M +38.91% | 213.26M +38.89% | 203.33M +26.74% | 191.80M +8.58% | 187.32M -3.99% | 184.11M -13.67% | 183.99M -9.51% | 189.68M -1.11% | 179.96M -3.93% | 196.64M +6.81% | 197.88M +7.55% | 200.61M +5.76% | 195.25M +8.50% | 198.58M +0.99% | 202.97M +2.57% | 203.07M +1.23% | 196.03M +0.40% | 194.78M -1.91% | 796.85M -- |
Sales and Services Revenue | 101.75M -- | 102.70M -- | 133.41M -- | 123.30M -- | 140.45M +38.04% | 140.97M +37.27% | 160.43M +20.26% | 176.63M +43.26% | 195.10M +38.91% | 194.46M +37.94% | 203.33M +26.74% | 191.80M +8.58% | 187.32M -3.99% | 163.68M -15.83% | 183.99M -9.51% | 189.68M -1.11% | 174.56M -6.81% | 191.42M +16.94% | 192.50M +4.63% | 195.21M +2.91% | 189.86M +8.76% | 193.75M +1.22% | 198.59M +3.16% | 198.51M +1.69% | 191.39M +0.81% | 190.62M -1.62% | 779.11M -- |
Other Revenue | -- -- | 10.56M -- | -- -- | -- -- | -- -- | 12.57M +19.06% | -- -- | -- -- | -- -- | 18.79M +49.51% | -- -- | -- -- | -- -- | 20.43M +8.70% | -- -- | -- -- | 5.39M -- | 5.23M -74.41% | 5.38M -- | 5.41M -- | 5.39M -0.07% | 4.83M -7.57% | 4.38M -18.47% | 4.56M -15.60% | 4.64M -13.95% | 4.16M -13.82% | 17.75M -- |
Cost of Revenue | 3.40M -- | 4.60M -- | 6.02M -- | 6.82M -- | 7.54M +122.03% | 9.20M +100.26% | 10.43M +73.25% | 11.09M +62.51% | 11.27M +49.48% | 13.93M +51.31% | 12.28M +17.76% | 18.04M +62.71% | 17.39M +54.33% | 17.36M +24.65% | 16.70M +35.95% | 16.34M -9.45% | 18.72M +7.62% | 15.17M -12.62% | 12.47M -25.32% | 11.87M -27.35% | 11.68M -37.59% | 12.19M -19.62% | 13.36M +7.19% | 13.35M +12.47% | 13.42M +14.85% | 17.46M +43.23% | 57.60M -- |
Cost of Goods and Services | -- -- | 14.02M -- | -- -- | -- -- | -- -- | 29.59M +111.09% | -- -- | -- -- | -- -- | 46.72M +57.89% | -- -- | -- -- | -- -- | 65.08M +39.31% | -- -- | -- -- | 18.72M -- | 15.17M -76.69% | 12.47M -- | 11.87M -- | 11.68M -37.59% | 12.19M -19.62% | 13.36M +7.19% | 13.35M +12.47% | 13.42M +14.85% | 17.46M +43.23% | 57.60M -- |
Gross Profit | 98.35M -- | 108.66M -- | 127.39M -- | 116.47M -- | 132.91M +35.14% | 144.34M +32.84% | 150.00M +17.75% | 165.54M +42.13% | 183.83M +38.31% | 199.33M +38.10% | 191.05M +27.36% | 173.75M +4.96% | 169.92M -7.57% | 166.75M -16.34% | 167.29M -12.44% | 173.34M -0.24% | 161.24M -5.11% | 181.47M +8.83% | 185.41M +10.83% | 188.74M +8.89% | 183.57M +13.85% | 186.39M +2.71% | 189.61M +2.26% | 189.72M +0.52% | 182.61M -0.52% | 177.32M -4.87% | 739.26M -- |
Operating Expenses | 60.51M -- | 72.89M -- | 83.72M -- | 74.73M -- | 194.60M +221.62% | 443.78M +508.81% | 155.00M +85.14% | 165.90M +121.98% | 176.83M -9.13% | 187.57M -57.73% | 171.29M +10.51% | 177.80M +7.18% | 185.64M +4.98% | 165.01M -12.03% | 155.99M -8.93% | 155.03M -12.81% | 199.57M +7.50% | 199.76M +21.06% | 178.03M +14.13% | 168.86M +8.92% | 163.16M -18.24% | 168.21M -15.79% | 166.23M -6.63% | 162.91M -3.52% | 167.99M +2.96% | 154.64M -8.07% | 651.76M -- |
Selling, General and Administrative Expenses | 52.66M -- | 63.07M -- | 73.39M -- | 62.77M -- | 178.75M +239.44% | 420.10M +566.05% | 128.84M +75.55% | 136.33M +117.18% | 141.76M -20.70% | 152.51M -63.70% | 136.25M +5.75% | 142.40M +4.45% | 149.72M +5.61% | 128.24M -15.91% | 123.08M -9.66% | 123.75M -13.10% | 159.96M +6.84% | 167.73M +30.79% | 147.01M +19.45% | 138.01M +11.53% | 133.02M -16.84% | 136.47M -18.64% | 135.08M -8.11% | 132.98M -3.64% | 136.98M +2.97% | 125.70M -7.89% | 530.74M -- |
Selling and Marketing Expenses | -- -- | 176.97M -- | -- -- | -- -- | -- -- | 255.13M +44.17% | -- -- | -- -- | -- -- | 370.22M +45.11% | -- -- | -- -- | -- -- | 357.63M -3.40% | -- -- | -- -- | 91.61M -- | 93.75M -73.79% | 89.96M -- | 93.45M -- | 89.87M -1.91% | 93.83M +0.08% | 84.54M -6.03% | 84.87M -9.19% | 83.53M -7.05% | 78.62M -16.21% | 331.56M -- |
General and Administrative Expenses | -- -- | 14.69M -- | -- -- | -- -- | -- -- | 461.45M +3040.83% | -- -- | -- -- | -- -- | 154.69M -66.48% | -- -- | -- -- | -- -- | 144.79M -6.40% | -- -- | -- -- | 35.32M -- | 30.37M -79.02% | 41.11M -- | 27.59M -- | 25.62M -27.46% | 23.55M -22.47% | 29.63M -27.92% | 28.38M +2.86% | 32.01M +24.96% | 23.94M +1.66% | 113.96M -- |
Research and Development Expenses | 7.84M -- | 9.82M -- | 10.32M -- | 11.96M -- | 15.85M +102.01% | 23.68M +141.17% | 26.16M +153.37% | 29.57M +147.17% | 35.07M +121.34% | 35.06M +48.04% | 35.04M +33.95% | 35.40M +19.74% | 35.92M +2.42% | 36.77M +4.88% | 32.91M -6.09% | 31.29M -11.63% | 39.61M +10.27% | 32.03M -12.89% | 31.02M -5.75% | 30.85M -1.38% | 30.14M -23.91% | 31.74M -0.91% | 31.14M +0.40% | 29.93M -2.99% | 31.01M +2.90% | 28.94M -8.82% | 121.03M -- |
Operating Income | 37.84M -- | 35.77M -- | 43.67M -- | 41.74M -- | -61.69M -263.00% | -299.44M -937.20% | -5.00M -111.44% | -351.00K -100.84% | 7.00M +111.35% | 11.76M +103.93% | 19.76M +495.38% | -4.05M -1052.99% | -15.71M -324.50% | 1.74M -85.22% | 11.30M -42.80% | 18.31M +552.38% | -38.33M -143.94% | -18.29M -1152.85% | 7.38M -34.70% | 19.88M +8.58% | 20.41M +153.24% | 18.18M +199.41% | 23.38M +216.76% | 26.81M +34.87% | 14.62M -28.36% | 22.68M +24.77% | 87.49M -- |
Non-Operating Income (Loss) | -12.50M -- | -17.83M -- | -8.56M -- | -6.74M -- | -6.24M +50.06% | -6.19M +65.26% | -5.89M +31.19% | -5.89M +12.54% | -5.92M +5.22% | -5.89M +4.97% | -5.82M +1.22% | -6.11M -3.72% | -6.56M -10.87% | -6.48M -10.13% | -7.71M -32.49% | -6.24M -2.09% | -8.27M -26.12% | -6.35M +2.08% | -7.09M +8.03% | -8.23M -31.92% | -12.29M -48.65% | -6.77M -6.68% | -6.71M +5.30% | -7.23M +12.15% | -8.52M +30.70% | -8.49M -25.39% | -30.95M -- |
Other Non-Operating Income (Loss) | 4.00K -- | -7.85M -- | 5.00K -- | 16.00K -- | -1.00K -125.00% | 2.00K +100.03% | -- -- | -- -- | -- -- | 0 -100.00% | 0 -- | 0 -- | 0 -- | 0 -- | -1.81M -- | -- -- | -2.20M -- | 0 -- | -- -- | 0 -- | -4.74M -115.32% | 0 -- | -- -- | 694.00K -- | 0 +100.00% | 24.00K -- | -- -- |
Net Interest Expense | 12.50M -- | 9.98M -- | 8.56M -- | 6.75M -- | 6.24M -50.09% | 6.20M -37.93% | 5.89M -31.23% | 5.89M -12.75% | 5.92M -5.21% | 5.89M -5.00% | 5.82M -1.22% | 6.11M +3.72% | 6.56M +10.87% | 6.48M +10.13% | 5.90M +1.41% | 6.24M +2.09% | 6.07M -7.43% | 6.35M -2.08% | 7.09M +20.16% | 8.23M +31.92% | 7.56M +24.49% | 6.77M +6.68% | 6.71M -5.30% | 7.93M -3.72% | 8.52M +12.73% | 8.51M +25.74% | 31.67M -- |
Interest Expense | 12.77M -- | 10.12M -- | 8.64M -- | 6.79M -- | 6.26M -50.96% | 6.22M -38.56% | 5.91M -31.64% | 5.91M -13.08% | 5.93M -5.36% | 5.90M -5.04% | 5.87M -0.61% | 6.97M +18.00% | 9.48M +59.89% | 11.93M +102.05% | 13.13M +123.77% | 14.05M +101.66% | 14.72M +55.31% | 14.82M +24.26% | 14.64M +11.50% | 14.57M +3.64% | 12.36M -16.07% | 11.36M -23.37% | 10.64M -27.31% | 10.73M -26.34% | 10.83M -12.35% | 10.40M -8.41% | 42.60M -- |
Interest Income | 271.00K -- | 135.00K -- | 75.00K -- | 41.00K -- | 24.00K -91.14% | 20.00K -85.19% | 16.00K -78.67% | 13.00K -68.29% | 13.00K -45.83% | 17.00K -15.00% | 52.00K +225.00% | 857.00K +6492.31% | 2.92M +22361.54% | 5.45M +31929.41% | 7.23M +13811.54% | 7.81M +811.79% | 8.65M +196.20% | 8.47M +55.63% | 7.55M +4.44% | 6.33M -18.94% | 4.80M -44.54% | 4.59M -45.87% | 3.93M -47.95% | 2.80M -55.75% | 2.31M -51.87% | 1.89M -58.82% | 10.93M -- |
Pretax Income From Continuing Operations | 25.35M -- | 17.94M -- | 35.11M -- | 35.00M -- | -67.93M -367.99% | -305.63M -1803.84% | -10.89M -131.01% | -6.24M -117.84% | 1.08M +101.60% | 5.87M +101.92% | 13.94M +228.08% | -10.16M -62.70% | -22.27M -2154.52% | -4.75M -180.83% | 3.60M -74.21% | 12.07M +218.79% | -46.60M -109.25% | -24.64M -419.18% | 293.00K -91.85% | 11.65M -3.50% | 8.11M +117.41% | 11.41M +146.31% | 16.67M +5588.74% | 19.58M +68.10% | 6.10M -24.80% | 14.19M +24.40% | 56.54M -- |
Income Tax Expense | 5.73M -- | 2.71M -- | 7.77M -- | 7.66M -- | -17.89M -412.45% | -7.36M -371.49% | -12.55M -261.67% | -37.30M -586.95% | 19.15M +207.04% | 45.78M +722.07% | 1.65M +113.15% | -8.74M +76.56% | 19.46M +1.62% | -2.77M -106.06% | 6.89M +317.08% | -46.72M -434.29% | -8.11M -141.65% | 1.23M +144.50% | 1.30M -81.09% | 4.95M +110.60% | 4.15M +151.16% | 4.67M +278.36% | 5.62M +331.34% | 6.73M +35.99% | 4.98M +20.11% | 8.77M +87.79% | 26.10M -- |
Current Income Tax | -- -- | 22.60M -- | -- -- | -- -- | -- -- | 1.08M -95.21% | -- -- | -- -- | -- -- | 2.17M +100.46% | -- -- | -- -- | -- -- | 10.09M +364.95% | -- -- | -- -- | -- -- | 18.86M +86.82% | -- -- | -- -- | -- -- | 26.98M +43.09% | -- -- | -- -- | -- -- | 6.03M -77.66% | -- -- |
Deferred Income Tax | -- -- | -5.67M -- | -- -- | -- -- | -- -- | -10.91M -92.28% | -- -- | -- -- | -- -- | 12.91M +218.30% | -- -- | -- -- | -- -- | -497.00K -103.85% | -- -- | -- -- | -- -- | -65.56M -13091.55% | -- -- | -- -- | -- -- | -11.91M +81.83% | -- -- | -- -- | -- -- | 20.07M +268.47% | -- -- |
Net Income | 19.62M -- | 15.23M -- | 27.35M -- | 27.34M -- | -50.03M -355.02% | -298.27M -2058.85% | 1.67M -93.90% | 31.06M +13.62% | -18.07M +63.89% | -39.91M +86.62% | 12.29M +636.99% | -1.42M -104.56% | -41.73M -130.97% | -1.97M +95.06% | -3.29M -126.76% | 58.79M +4254.49% | -38.49M +7.76% | -25.87M -1211.82% | -1.01M +69.33% | 6.69M -88.61% | 3.96M +110.30% | 6.74M +126.05% | 11.05M +1195.34% | 12.84M +91.86% | 1.12M -71.78% | 5.42M -19.51% | 30.44M -- |
Net Income Attributable to Owners of the Company | 19.62M -- | 15.23M -- | 27.35M -- | 27.34M -- | -50.03M -355.02% | -298.27M -2058.85% | 1.67M -93.90% | 31.06M +13.62% | -18.07M +63.89% | -39.91M +86.62% | 12.29M +636.99% | -1.42M -104.56% | -41.73M -130.97% | -1.97M +95.06% | -3.29M -126.76% | 58.79M +4254.49% | -38.49M +7.76% | -25.87M -1211.82% | -1.01M +69.33% | 6.69M -88.61% | 3.96M +110.30% | 6.74M +126.05% | 11.05M +1195.34% | 12.84M +91.86% | 1.12M -71.78% | 5.42M -19.51% | 30.44M -- |
Preferred Stock Dividends | -- -- | 23.61M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | 19.62M -- | -8.38M -- | 27.35M -- | 27.34M -- | -50.03M -355.02% | -298.27M -3459.36% | 1.67M -93.90% | 31.06M +13.62% | -18.07M +63.89% | -39.91M +86.62% | 12.29M +636.99% | -1.42M -104.56% | -41.73M -130.97% | -1.97M +95.06% | -3.29M -126.76% | 58.79M +4254.49% | -38.49M +7.76% | -25.87M -1211.82% | -1.01M +69.33% | 6.69M -88.61% | 3.96M +110.30% | 6.74M +126.05% | 11.05M +1195.34% | 12.84M +91.86% | 1.12M -71.78% | 5.42M -19.51% | 30.44M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | 66.05M -- | -- -- | -- -- | -- -- | -293.62M -544.56% | -- -- | -- -- | -- -- | -25.25M +91.40% | -- -- | -- -- | -- -- | -32.83M -29.99% | -- -- | -- -- | -38.49M -- | -17.00M +48.21% | -1.01M -- | 6.69M -- | 3.96M +110.30% | -9.65M +43.24% | 11.05M +1195.34% | 12.84M +91.86% | 1.12M -71.78% | -25.01M -159.21% | -- -- |
Basic EPS | 0.06 -- | -- -- | 0.08 -- | 0.08 -- | -0.21 -450.00% | -0.76 -- | 0 -100.00% | 0.08 -- | -0.04 +80.95% | -0.1 +86.84% | 0.03 -- | 0 -100.00% | -0.1 -150.00% | 0 +100.00% | -0.01 -133.33% | 0.14 -- | -0.09 +10.00% | -0.07 -- | 0 +100.00% | 0.02 -85.71% | 0.01 +111.11% | 0.02 +128.57% | 0.03 -- | 0.04 +100.00% | 0 -100.00% | 0.02 -- | 0.09 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.09 -- | -- -- | 0 -- | 0.02 -- | 0.01 +111.11% | -- -- | 0.03 -- | 0.04 +100.00% | 0 -100.00% | -- -- | -- -- |
Diluted EPS | 0.05 -- | -- -- | 0.08 -- | 0.08 -- | -0.21 -520.00% | -- -- | 0 -100.00% | 0.07 -12.50% | -0.04 +80.95% | -- -- | 0.03 -- | 0 -100.00% | -0.1 -150.00% | -- -- | -0.01 -133.33% | 0.14 -- | -0.09 +10.00% | -- -- | 0 +100.00% | 0.02 -85.71% | 0.01 +111.11% | 0.02 -- | 0.03 -- | 0.04 +100.00% | 0 -100.00% | 0.02 -- | 0.09 -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.09 -- | -- -- | 0 -- | 0.02 -- | 0.01 +111.11% | -- -- | 0.03 -- | 0.04 +100.00% | 0 -100.00% | -- -- | -- -- |
You can ask Aime
What is Goodrx's gross profit margin?What were the key takeaways from Goodrx’s earnings call?What is the market's earnings forecast for Goodrx next quarter?What guidance did Goodrx's management provide for the next earnings period?What is the revenue and EPS growth rate for Goodrx year over year?What were the key takeaways from Goodrx's earnings call?What factors drove the changes in Goodrx's revenue and profit?What is Goodrx's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
